Attys For Gilead, Drug Buyers Trade Barbs As $3.6B Trial Ends
By Bonnie Eslinger · June 28, 2023, 9:16 PM EDT
Gilead's lawyer on Wednesday slammed a $3.6 billion antitrust suit alleging an illegal "pay-for-delay" deal with Teva over two HIV drugs during closing arguments, calling the plaintiffs' theory a "house of...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login